Anti-Inhibitor Coagulant Complex Prophylaxis in Hemophilia with Inhibitors

Abstract

Patients with severe hemophilia A and factor VIII inhibitors are at increased risk for serious bleeding complications and progression to end-stage joint disease. Effective strategies to prevent bleeding in such patients have not yet been established.